Newest! 2018 FDA drug review report
-
Last Update: 2018-12-14
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Recently, CDER under FDA released the drug review report for 2018 (as of November 30) So far, FDA has approved 55 new molecular entities (NME), 41 of which are NDA and 14 are bla, a new record Among these new drugs, more than half of them have obtained the qualification of orphan drugs, 30 of which have obtained the qualification of orphan drugs, including 9 Blas and 21 NDA (for details of orphan drugs, please refer to the article "[inventory] new orphan drugs approved by FDA in 2018, a new record!") The following is the full text of the report If you need PDF version, you can add personal wechat of Xiaozhi (wechat: Yaozhi Wang) and reply to "2018 FDA drug review report".
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
